Veklury performs better the sooner it's given, Gilead says in new study and real-world analysis
While some studies and analyses have claimed that Veklury is ineffective for treating Covid-19, Gilead is firing back — and this time, it has some data …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
